A cooperative model may at time better serve the relationship between patient and clinician.

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

Researchers reviewed cases in which patients experienced severe skin toxicities in response to immunotherapy, and sought to identify the distinct natures of these toxicities.

To our knowledge, this is the first study that demonstrates a clinical advantage of proton therapy for NGGCT,” said David Y. Mak, MD.

This study examined the posttreatment experiences of 7 children with brain tumor to determine whether problems with cognition, body function, and social functioning improved over time.

The proportion of patients who receive a long-term opioid prescription following colorectal surgery has significantly decreased over time.

Sacituzumab tirumotecan showed “promising efficacy” regardless of PD-L1 status, said study presenter Yongmei Yin, MD, PhD.

HealthDay News — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...

Researchers sought to determine whether SOC pola-R-CHP frontline therapy would be safe and effective in a real-world population of patients with treatment-naïve DLBCL.

A dedicated discharge team, standardized education, a mandatory 24-hour room-in for caregivers, and appointments with a pharmacist are features that ensure a safe transition from hospital to home for ...

Amid the growing popularity of cannabis, it is perhaps not surprising that clinicians are increasingly accepting its use among cancer survivors,” the researchers wrote.

A higher NLR and rapid NLR shift between weeks 2 and 4 was strongly associated with RILD risk in patients with HCC.